CAPRICOR THERAPEUTICS, INC. 14070B309 US14070B3096 BBG000DZMK99 6/4/2026 APPROVAL OF NAMED EXECUTIVE OFFICER COMPENSATION, ON A NON-BINDING ADVISORY BASIS SECTION 14A SAY-ON-PAY VOTES ISSUER 106563 7336 FOR 106563 FOR CAPRICOR THERAPEUTICS, INC. 14070B309 US14070B3096 BBG000DZMK99 6/4/2026 APPROVAL OF FREQUENCY OF FUTURE NON-BINDING ADVISORY VOTES ON NAMED EXECUTIVE OFFICER COMPENSATION, ON A NON-BINDING ADVISORY BASIS SECTION 14A SAY-ON-PAY VOTES ISSUER 106563 7336 FOR 106563 FOR PERSPECTIVE THERAPEUTICS INC 46489V302 US46489V3024 BBG000BG5HT7 5/27/2026 To approve, on a non-binding advisory basis, the frequency of advisory stockholder votes on the compensation of the Company's name executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1454261 0 FOR 1454261 FOR MINERVA NEUROSCIENCES INC 603380205 US6033802058 BBG0067S9Z73 6/3/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the accompanying proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 1412069 243431 FOR 1412069 FOR MINERVA NEUROSCIENCES INC 603380205 US6033802058 BBG0067S9Z73 6/3/2026 To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1412069 243431 FOR 1412069 FOR 1 Year EDGEWISE THERAPEUTICS INC 28036F105 US28036F1057 BBG00K4Y2H24 6/4/2026 Conduct an advisory vote on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 29439 93561 FOR 29439 FOR COMPASS PATHWAYS PLC 20451W101 US20451W1018 BBG00X0VY2N1 5/27/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers for the year ended December 31, 2025. SECTION 14A SAY-ON-PAY VOTES ISSUER 931039 114516 FOR 931039 FOR SOLID BIOSCIENCES INC. 83422E204 US83422E2046 BBG00JN4FXG8 6/10/2026 The approval of an advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 358257 0 FOR 358257 FOR WHITEHAWK THERAPEUTICS, INC 00032Q104 US00032Q1040 BBG002WN7DT2 6/11/2026 To approve, on an advisory basis, the compensation of the named executive officers identified in the 2025 Summary Compensation Table in the "Executive Compensation" section of the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 779306 38633 FOR 779306 FOR CYTOMX THERAPEUTICS, INC. 23284F105 US23284F1057 BBG001J472L3 6/17/2026 To approve, on a nonbinding advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement accompanying this Notice of Annual Meeting of Stockholders. SECTION 14A SAY-ON-PAY VOTES ISSUER 560000 0 FOR 560000 FOR CYTOMX THERAPEUTICS, INC. 23284F105 US23284F1057 BBG001J472L3 6/17/2026 To hold a non-binding advisory vote on the frequency of future advisory votes by stockholders on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 560000 0 FOR 560000 FOR 1 year OVID THERAPEUTICS INC. 690469101 US6904691010 BBG009F0TD76 6/10/2026 Advisory approval of the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1244405 0 FOR 1244405 FOR PRAXIS PRECISION MEDICINES, Inc. 74006W207 US74006W2070 BBG00W9LF2G5 6/10/2026 To approve, on an advisory (non-binding) basis, the compensation of the named executive officers as disclosed in the Company's proxy statement for the 2026 Annual Meeting of Stockholders pursuant to the applicable compensation disclosure rules of the SEC, including the Compensation Discussion and Analysis, the compensation tables and narrative discussion. SECTION 14A SAY-ON-PAY VOTES ISSUER 10534 6000 FOR 10534 FOR UROGEN PHARMA LTD M96088105 IL0011407140 BBG00GFCC613 6/22/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's proxy statement for the Annual Meeting. SECTION 14A SAY-ON-PAY VOTES ISSUER 302433 0 FOR 302433 FOR INHIBIKASE THERAPEUTICS, INC. 45719W205 US45719W2052 BBG005TP2339 6/26/2026 to approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 355610 500533 FOR 355610 FOR INHIBIKASE THERAPEUTICS, INC. 45719W205 US45719W2052 BBG005TP2339 6/26/2026 to vote, on a non-binding, advisory basis, on the frequency of future non-binding, advisory votes on compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 355610 500533 FOR 355610 FOR 1 year TARSUS PHARMACEUTICALS, INC. 87650L103 US87650L1035 BBG00RB9BNQ7 6/24/2026 To hold an advisory vote to approve, on a non-binding basis, our named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 81592 20856 FOR 81592 FOR